scispace - formally typeset
D

Denise Guetard

Researcher at Pasteur Institute

Publications -  131
Citations -  10118

Denise Guetard is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Virus & Antigen. The author has an hindex of 37, co-authored 131 publications receiving 9903 citations. Previous affiliations of Denise Guetard include Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

TL;DR: Preincubation of T4+ lymphocytes with three individual monoclonal antibodies directed at the T4 glycoprotein blocked cell infection by LAV, strongly support the view that a surface molecule directly involved in cellular functions acts as, or is related to, the receptor for a human retrovirus.
Journal ArticleDOI

Isolation of a new human retrovirus from West African patients with AIDS.

TL;DR: It is established that this new retrovirus, here referred to as LAV-II, is distantly related to LAV and distinct from STLV-IIImac, suggesting that the West African AIDS virus may be more closely related to this simian virus than toLAV.
Journal ArticleDOI

HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap

TL;DR: It is shown here that the central DNA flap acts as a cis-determinant of HIV-1 DNA nuclear import, which can be corrected to wild-type levels by reinsertion of the DNA flap sequence.
Journal ArticleDOI

Molecular cloning and polymorphism of the human immune deficiency virus type 2

TL;DR: The molecular cloning of the complete 9.5-kilobase (kb) genome of HIV-2 is reported, the observation of restriction site polymorphism between different isolates, and a preliminary analysis of the relationship ofAIDS-2 with other human and simian retroviruses is analyzed.
Journal ArticleDOI

Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

TL;DR: A strain of lymphadenopathy associated retrovirus passaged in vitro was used to infect a lymphoblastoid cell line obtained by transformation with Epstein-Barr virus of B lymphocytes from a healthy donor, and this adapted strain retained the biochemical, ultrastructural, and antigenic characteristics of the original strain.